Indicated for: cancer
Route of administration: infusion
Substance: carboplatin (antineoplastic agent)
ATC: L01XA02 (Antineoplastic and immunomodulating agents | Other antineoplastic agents | Platinum compounds)
Carboplatin is a chemotherapy medication used to treat various types of cancer, including ovarian, lung, bladder, and breast cancer. It belongs to the class of platinum-based compounds and works by interfering with the DNA of cancer cells, inhibiting their division and growth.
Carboplatin is administered intravenously, usually in cycles, and the dosage is adjusted based on the patient's weight, kidney function, and the type of cancer being treated. It is often used in combination with other chemotherapy drugs to enhance treatment effectiveness.
Patients need to be closely monitored during treatment to detect potential side effects, such as a decrease in blood cell counts, nausea, or kidney toxicity. It is important to strictly follow the doctor's instructions.
Common side effects include fatigue, nausea, vomiting, loss of appetite, and an increased risk of infections. In rare cases, severe allergic reactions or hearing loss may occur. Patients should inform their doctor of any unusual symptoms.